Denali Therapeutics (DNLI) News Today $14.64 -0.72 (-4.69%) Closing price 04:00 PM EasternExtended Trading$14.72 +0.08 (+0.58%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DNLI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cantor Fitzgerald Reiterates "Overweight" Rating for Denali Therapeutics (NASDAQ:DNLI)September 10 at 9:59 AM | marketbeat.comAlliancebernstein L.P. Cuts Stock Position in Denali Therapeutics Inc. $DNLISeptember 10 at 3:53 AM | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Sold by Yiheng Capital Management L.P.September 9 at 7:37 AM | marketbeat.comPolar Asset Management Partners Inc. Has $285,000 Holdings in Denali Therapeutics Inc. $DNLISeptember 9 at 5:21 AM | marketbeat.comDenali Therapeutics Inc. (DNLI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9 at 3:05 AM | seekingalpha.comGraham Capital Management L.P. Boosts Position in Denali Therapeutics Inc. $DNLISeptember 8 at 4:35 AM | marketbeat.comTrexquant Investment LP Buys 52,568 Shares of Denali Therapeutics Inc. $DNLISeptember 8 at 3:51 AM | marketbeat.comCrestline Management LP Lowers Position in Denali Therapeutics Inc. $DNLISeptember 6, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Sold by ADAR1 Capital Management LLCSeptember 5, 2025 | marketbeat.comNorthern Trust Corp Has $15.39 Million Position in Denali Therapeutics Inc. $DNLISeptember 4, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Bought by Walleye Capital LLCSeptember 3, 2025 | marketbeat.comHsbc Holdings PLC Boosts Stock Position in Denali Therapeutics Inc. $DNLISeptember 2, 2025 | marketbeat.comDAFNA Capital Management LLC Invests $1.74 Million in Denali Therapeutics Inc. $DNLISeptember 1, 2025 | marketbeat.comAmerican Century Companies Inc. Reduces Holdings in Denali Therapeutics Inc. $DNLISeptember 1, 2025 | marketbeat.comInvesco Ltd. Buys 67,949 Shares of Denali Therapeutics Inc. $DNLISeptember 1, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Acquired by AlphaQuest LLCAugust 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Purchases 1,308,619 Shares of Denali Therapeutics Inc. $DNLIAugust 29, 2025 | marketbeat.comNuveen LLC Acquires Shares of 322,945 Denali Therapeutics Inc. $DNLIAugust 29, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 18,566 Shares of Denali Therapeutics Inc. $DNLIAugust 26, 2025 | marketbeat.comDenali Therapeutics Inc. (NASDAQ:DNLI) Given Average Recommendation of "Buy" by AnalystsAugust 25, 2025 | marketbeat.comCandriam S.C.A. Has $11.67 Million Holdings in Denali Therapeutics Inc. $DNLIAugust 24, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Purchased by Wellington Management Group LLPAugust 23, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Sold by Deutsche Bank AGAugust 23, 2025 | marketbeat.comVanguard Group Inc. Has $160.42 Million Stake in Denali Therapeutics Inc. $DNLIAugust 23, 2025 | marketbeat.comGroupama Asset Managment Acquires 34,281 Shares of Denali Therapeutics Inc. $DNLIAugust 22, 2025 | marketbeat.comDenali Therapeutics Inc. $DNLI Shares Bought by Aberdeen Group plcAugust 22, 2025 | marketbeat.comDenali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $30.00 at Morgan StanleyAugust 20, 2025 | marketbeat.comB. Riley Research Analysts Lift Earnings Estimates for DNLIAugust 19, 2025 | marketbeat.comEquities Analysts Set Expectations for DNLI FY2029 EarningsAugust 17, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic Outlook of DNLI Q4 EarningsAugust 17, 2025 | marketbeat.comHC Wainwright Has Negative Outlook for DNLI FY2025 EarningsAugust 17, 2025 | marketbeat.comEquities Analysts Issue Forecasts for DNLI FY2025 EarningsAugust 17, 2025 | marketbeat.comDenali Therapeutics Inc. (NASDAQ:DNLI) Insider Sells $11,799.84 in StockAugust 16, 2025 | marketbeat.comInsider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Insider Sells 2,937 Shares of StockAugust 16, 2025 | marketbeat.comCarole Ho Sells 2,937 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) StockAugust 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for DNLI FY2028 Earnings?August 16, 2025 | marketbeat.comCantor Fitzgerald Has Weak Outlook for DNLI FY2025 EarningsAugust 16, 2025 | marketbeat.comWilliam Blair Brokers Boost Earnings Estimates for DNLIAugust 16, 2025 | marketbeat.comDenali Therapeutics (NASDAQ:DNLI) Trading 11.1% Higher - Still a Buy?August 15, 2025 | marketbeat.comDenali Therapeutics Inc. (NASDAQ:DNLI) Insider Carole Ho Sells 806 SharesAugust 15, 2025 | insidertrades.comDenali Therapeutics (NASDAQ:DNLI) Shares Down 5.1% - Here's WhyAugust 13, 2025 | marketbeat.comDenali Therapeutics (NASDAQ:DNLI) Announces Quarterly Earnings ResultsAugust 12, 2025 | marketbeat.comDenali Therapeutics Inc.: Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business HighlightsAugust 12, 2025 | finanznachrichten.deDenali Therapeutics Reports Second Quarter 2025 Financial Results and Business HighlightsAugust 11, 2025 | globenewswire.com18,699 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Universal Beteiligungs und Servicegesellschaft mbHAugust 5, 2025 | marketbeat.comTD Asset Management Inc Grows Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)August 3, 2025 | marketbeat.comDenali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome TherapyJuly 31, 2025 | msn.comDenali Therapeutics (DNLI) Projected to Post Earnings on ThursdayJuly 31, 2025 | marketbeat.comDenali Therapeutics (NASDAQ:DNLI) Upgraded at TD CowenJuly 29, 2025 | marketbeat.comY Intercept Hong Kong Ltd Boosts Position in Denali Therapeutics Inc. (NASDAQ:DNLI)July 27, 2025 | marketbeat.com Get Denali Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DNLI Media Mentions By Week DNLI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNLI News Sentiment▼1.400.84▲Average Medical News Sentiment DNLI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNLI Articles This Week▼116▲DNLI Articles Average Week Get the Latest News and Ratings for DNLI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Denali Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beam Therapeutics News Today Roivant Sciences News Today Revolution Medicines News Today Grifols News Today Rhythm Pharmaceuticals News Today Legend Biotech News Today Abivax News Today Axsome Therapeutics News Today Avidity Biosciences News Today Nuvalent News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DNLI) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Denali Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNLI Stock Alerts